title: [Drug utilization decisions should be based on cost-benefit data].
authors.affiliation: Centrum för hälsoekonomi, Handelshögskolan i Stockholm.
authors.forename: Jönsson
authors.initials: J
authors.lastname: Bengt
authors.forename: Göran
authors.initials: G
authors.lastname: Arvidsson
authors.forename: Lars-Ake
authors.initials: LA
authors.lastname: Levin
authors.forename: Claes
authors.initials: C
authors.lastname: Rehnberg
mesh_terms: D003362:Cost-Benefit Analysis; D003657:Decision Making; D016527:Drug Costs; D011307:Drug Prescriptions / Q000191:economics*; D004363:Drug Utilization / Q000191:economics*; D019317:Evidence-Based Medicine; D006291:Health Policy; D006801:Humans